Eli Mordechai

Medical Diagnostic Laboratories (United States)

Papers

1

Total Citations

23

H-Index

1

About

Eli Mordechai is a distinguished researcher whose work has significantly advanced the understanding of bacterial vaginosis (BV) and its microbial underpinnings. His primary research areas include the molecular detection of vaginal pathogens and the complex polymicrobial interactions driving this common condition. Mordechai’s most notable contribution is his 2007 study on the rapid detection of *Atopobium vaginae*, a key but often overlooked bacterium in BV. This work, which has garnered 23 citations, was pioneering in establishing a sensitive PCR-based method to identify *A. vaginae* and, crucially, to link its presence with other organisms implicated in BV, such as *Gardnerella vaginalis*. By clarifying these microbial associations, Mordechai helped shift the paradigm from viewing BV as a single-pathogen infection to a multispecies dysbiosis. His findings have provided a foundation for improved diagnostic approaches and a deeper appreciation of the synergistic roles bacteria play in vaginal health. Through this focused yet impactful research, Mordechai has contributed essential tools and insights for clinicians and scientists working to unravel the etiology of BV and develop more effective treatments.

Research Focus

Key Achievements

1
H-Index
1
Papers
23
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Rapid detection of Atopobium vaginae and association with organisms implicated in bacterial vaginosis
23 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Medical Diagnostic Laboratories (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 7 days ago